These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25122051)

  • 1. WHO gives go ahead for experimental treatments to be used in Ebola outbreak.
    Sayburn A
    BMJ; 2014 Aug; 349():g5161. PubMed ID: 25122051
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical allocation of drugs and vaccines in the West African ebola epidemic.
    Gostin LO
    Milbank Q; 2014 Dec; 92(4):662-6. PubMed ID: 25492601
    [No Abstract]   [Full Text] [Related]  

  • 3. Ebola drug trials set to begin amid crisis.
    Butler D
    Nature; 2014 Sep; 513(7516):13-4. PubMed ID: 25186878
    [No Abstract]   [Full Text] [Related]  

  • 4. Scale up the supply of experimental Ebola drugs.
    Brady O
    Nature; 2014 Aug; 512(7514):233. PubMed ID: 25143079
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use.
    Hantel A; Olopade CO
    Ann Intern Med; 2015 Jan; 162(2):141-2. PubMed ID: 25322080
    [No Abstract]   [Full Text] [Related]  

  • 6. New rules needed to stop the Ebola epidemic.
    Hasle G
    Tidsskr Nor Laegeforen; 2014 Oct; 134(19):1826-7. PubMed ID: 25314981
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious diseases. Ebola drugs still stuck in lab.
    Enserink M
    Science; 2014 Jul; 345(6195):364-5. PubMed ID: 25061181
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO enters new terrain in Ebola research.
    Shuchman M
    CMAJ; 2014 Oct; 186(14):E527-8. PubMed ID: 25200757
    [No Abstract]   [Full Text] [Related]  

  • 9. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
    Cavaleri M; Thomson A; Salmonson T; Hemmings RJ
    Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolving Challenges and Research-Needs Concerning Ebola.
    Klitzman R
    Am J Public Health; 2015 Aug; 105(8):1513-5. PubMed ID: 26066956
    [No Abstract]   [Full Text] [Related]  

  • 11. Basic science and the Ebola virus infection epidemic.
    DeVane CL
    Pharmacotherapy; 2014 Nov; 34(11):1115-7. PubMed ID: 25382095
    [No Abstract]   [Full Text] [Related]  

  • 12. As Ebola epidemic begins to slow, trials of drugs and vaccines speed up.
    Kuehn BM
    JAMA; 2015 Mar; 313(10):1000-2. PubMed ID: 25671623
    [No Abstract]   [Full Text] [Related]  

  • 13. INFECTIOUS DISEASE. As Ebola epidemic draws to a close, a thin scientific harvest.
    Cohen J; Enserink M
    Science; 2016 Jan; 351(6268):12-3. PubMed ID: 26721981
    [No Abstract]   [Full Text] [Related]  

  • 14. Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.
    Espeland EM; Tsai CW; Larsen J; Disbrow GL
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006275. PubMed ID: 29621257
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental drugs poised for use in Ebola outbreak.
    Check Hayden E
    Nature; 2018 May; 557(7706):475-476. PubMed ID: 29789732
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of therapeutics for treatment of Ebola virus infection.
    Li H; Ying T; Yu F; Lu L; Jiang S
    Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola vaccine trials back on track.
    Mohammadi D
    Lancet; 2015 Jan; 385(9964):214-5. PubMed ID: 25601786
    [No Abstract]   [Full Text] [Related]  

  • 19. The year that Ebola virus took over west Africa: missed opportunities for prevention.
    Bausch DG
    Am J Trop Med Hyg; 2015 Feb; 92(2):229-232. PubMed ID: 25561568
    [No Abstract]   [Full Text] [Related]  

  • 20. A US Food and Drug Administration perspective on evaluating medical products for Ebola.
    Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L
    Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.